Caroline F. Wright

12.0k total citations · 1 hit paper
77 papers, 3.3k citations indexed

About

Caroline F. Wright is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Caroline F. Wright has authored 77 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Genetics, 25 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Caroline F. Wright's work include Genomics and Rare Diseases (44 papers), Genomic variations and chromosomal abnormalities (28 papers) and Cancer Genomics and Diagnostics (14 papers). Caroline F. Wright is often cited by papers focused on Genomics and Rare Diseases (44 papers), Genomic variations and chromosomal abnormalities (28 papers) and Cancer Genomics and Diagnostics (14 papers). Caroline F. Wright collaborates with scholars based in United Kingdom, United States and Australia. Caroline F. Wright's co-authors include Helen V. Firth, David Fitzpatrick, Jane Clarke, Matthew E. Hurles, H. Burton, Christopher M. Dobson, Sarah A. Teichmann, Eugene Bragin, Jeremy F. McRae and Alison Hall and has published in prestigious journals such as Nature, The Lancet and Nucleic Acids Research.

In The Last Decade

Caroline F. Wright

72 papers receiving 3.2k citations

Hit Papers

Paediatric genomics: diag... 2018 2026 2020 2023 2018 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Caroline F. Wright 1.8k 1.4k 461 306 305 77 3.3k
Tetsuya Sato 608 0.3× 1.6k 1.1× 380 0.8× 380 1.2× 201 0.7× 85 2.9k
Yinghua Shen 1.0k 0.5× 4.9k 3.4× 446 1.0× 440 1.4× 139 0.5× 17 5.5k
Michael J. Ziller 872 0.5× 4.0k 2.8× 290 0.6× 312 1.0× 106 0.3× 56 4.7k
Deanne Taylor 957 0.5× 1.2k 0.9× 1.4k 3.0× 200 0.7× 873 2.9× 98 3.3k
Dale L. Bodian 747 0.4× 1.5k 1.1× 115 0.2× 323 1.1× 102 0.3× 44 3.1k
Dorothy Warburton 1.3k 0.7× 2.0k 1.4× 1.3k 2.9× 214 0.7× 575 1.9× 90 4.1k
Kian Peng Koh 1.2k 0.6× 6.3k 4.4× 500 1.1× 876 2.9× 187 0.6× 28 7.3k
Emily Chen 875 0.5× 1.1k 0.8× 388 0.8× 286 0.9× 199 0.7× 97 3.3k
Mamta Tahiliani 1.5k 0.8× 7.7k 5.4× 575 1.2× 770 2.5× 211 0.7× 19 8.6k
Giuseppe Testa 1.0k 0.6× 3.6k 2.5× 172 0.4× 454 1.5× 234 0.8× 132 5.4k

Countries citing papers authored by Caroline F. Wright

Since Specialization
Citations

This map shows the geographic impact of Caroline F. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline F. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline F. Wright more than expected).

Fields of papers citing papers by Caroline F. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline F. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline F. Wright. The network helps show where Caroline F. Wright may publish in the future.

Co-authorship network of co-authors of Caroline F. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline F. Wright. A scholar is included among the top collaborators of Caroline F. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline F. Wright. Caroline F. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Leigh, et al.. (2025). What do we mean by actionability? Examining a key criterion in genomic prenatal and newborn screening. Genetics in Medicine. 28(1). 101624–101624.
2.
Chundru, V. Kartik, Leigh Jackson, Kashyap Patel, et al.. (2025). Whole-genome sequencing analysis identifies rare, large-effect noncoding variants and regulatory regions associated with circulating protein levels. Nature Genetics. 57(3). 626–634. 5 indexed citations
3.
Beaumont, Robin N., et al.. (2024). Genetic modifiers of rare variants in monogenic developmental disorder loci. Nature Genetics. 56(5). 861–868. 11 indexed citations
4.
Beaumont, Robin N., et al.. (2024). Clustering of predicted loss-of-function variants in genes linked with monogenic disease can explain incomplete penetrance. Genome Medicine. 16(1). 64–64. 1 indexed citations
5.
Wigdor, Emilie M., Kaitlin E. Samocha, Ruth Y. Eberhardt, et al.. (2024). Investigating the role of common cis-regulatory variants in modifying penetrance of putatively damaging, inherited variants in severe neurodevelopmental disorders. Scientific Reports. 14(1). 8708–8708.
6.
Ansari, Morad, et al.. (2024). Curating genomic disease-gene relationships with Gene2Phenotype (G2P). Genome Medicine. 16(1). 127–127. 2 indexed citations
7.
Colclough, Kevin, Caroline F. Wright, Sarah J. Pickett, et al.. (2023). Penetrance and expressivity of mitochondrial variants in a large clinically unselected population. Human Molecular Genetics. 33(5). 465–474. 6 indexed citations
8.
Shekari, Saleh, Stasa Stankovic, Eugene J. Gardner, et al.. (2023). Penetrance of pathogenic genetic variants associated with premature ovarian insufficiency. Nature Medicine. 29(7). 1692–1699. 32 indexed citations
9.
Gunning, Adam C. & Caroline F. Wright. (2023). Evaluating the use of paralogous protein domains to increase data availability for missense variant classification. Genome Medicine. 15(1). 110–110.
10.
Laver, Thomas W., Matthew N. Wakeling, Olivia Knox, et al.. (2022). Evaluation of Evidence for Pathogenicity Demonstrates That BLK , KLF11 , and PAX4 Should Not Be Included in Diagnostic Testing for MODY. Diabetes. 71(5). 1128–1136. 35 indexed citations
11.
Beaumont, Robin N., et al.. (2021). Common genetic variants with fetal effects on birth weight are enriched for proximity to genes implicated in rare developmental disorders. Human Molecular Genetics. 30(11). 1057–1066. 1 indexed citations
12.
Gunning, Adam C., James Fasham, Andrew H. Crosby, et al.. (2020). Assessing performance of pathogenicity predictors using clinically relevant variant datasets. Journal of Medical Genetics. 58(8). 547–555. 69 indexed citations
13.
Tuke, Marcus A., Jessica Tyrrell, Katherine S. Ruth, et al.. (2020). Large Copy-Number Variants in UK Biobank Caused by Clonal Hematopoiesis May Confound Penetrance Estimates. The American Journal of Human Genetics. 107(2). 325–329. 7 indexed citations
14.
Thormann, Anja, Mihail Halachev, William McLaren, et al.. (2019). Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nature Communications. 10(1). 2373–2373. 53 indexed citations
15.
Wright, Caroline F., Ben C. West, Marcus A. Tuke, et al.. (2019). Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting. The American Journal of Human Genetics. 104(2). 275–286. 109 indexed citations
16.
Bragin, Eugene, Caroline F. Wright, Matthew E. Hurles, et al.. (2013). DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Research. 42(D1). D993–D1000. 140 indexed citations
17.
Wright, Caroline F., et al.. (2012). Deciphering Developmental Disorders. Journal of Medical Genetics. 49. 32 indexed citations
18.
Moorthie, Sowmiya, Alison Hall, & Caroline F. Wright. (2012). Informatics and clinical genome sequencing: opening the black box. Genetics in Medicine. 15(3). 165–171. 24 indexed citations
19.
Wright, Caroline F., et al.. (2010). Size of the direct-to-consumer genomic testing market. Genetics in Medicine. 12(9). 594–594. 28 indexed citations
20.
Wright, Caroline F., Alison Hall, & Ron Zimmern. (2010). Regulating direct-to-consumer genetic tests: What is all the fuss about?. Genetics in Medicine. 13(4). 295–300. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026